来自爱尔兰儿科人口的过敏性鼻炎事实
Andreea Nae1, Colleen B Heffernan1, Michael Colreavy1
1Department of Otorhinolaryngology Ireland.
World journal of otorhinolaryngology - head and neck surgery
|December 7, 2023
概括
在一个大城市地区,室内灰尘和草花粉是影响过敏性鼻炎 (AR) 的儿童的主要过敏原. 这项研究强调了确定关键的环境过敏原对于有效的儿科AR管理的重要性.
科学领域:
- 儿科过敏和免疫学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
背景情况:
- 过敏性鼻炎 (AR) 是儿童常见的疾病,影响他们的生活质量.
- 识别流行过敏原对于有效诊断和治疗儿科AR至关重要.
研究的目的:
- 评估一个主要城市中心的儿科人口中导致过敏性鼻炎的主要过敏原.
- 了解疑似AR的儿童中对常见环境过敏原敏感性的流行情况.
主要方法:
- 五年来,回顾了可能出现过敏性鼻炎的患者的临床信件.
- 包括555名被诊断为AR的儿科患者,他们的诊断通过过敏原特定测试或临床评估得到证实.
主要成果:
- 家庭灰尘 (44.7%) 和草花粉 (29%) 是最常见的鉴定过敏原.
- 48%的患者对室内灰尘和草花粉都表现出敏感性.
- 与女性相比,男性患AR的可能性是男性的两倍.
结论:
- 大约一半的疑似AR儿童已证实对环境过敏原的敏感性.
- 儿科耳鼻喉科医生的临床诊断也是AR诊断的一个重要因素.
- 这些发现为临床医生提供了有价值的数据,以根据普遍存在的局部过敏原来定制AR治疗.
相关概念视频
Allergic Reactions
27.5K
Overview
27.5K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management
411
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
411
Drugs Used in Lower Respiratory Disorders: Overview
451
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
451
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
305
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
305


